The store will not work correctly when cookies are disabled.
3-(N-Hydroxy-N-methylcarbamoyl)-2-(3,4-dichlorophenyl)-propylphosphonic Acid Bisammonium Salt
ID: ALA3422251
Chembl Id: CHEMBL3422251
PubChem CID: 145948545
Max Phase: Preclinical
Molecular Formula: C11H20Cl2N3O5P
Molecular Weight: 342.12
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CN(O)C(=O)CC(CP(=O)(O)O)c1ccc(Cl)c(Cl)c1.N.N
Standard InChI: InChI=1S/C11H14Cl2NO5P.2H3N/c1-14(16)11(15)5-8(6-20(17,18)19)7-2-3-9(12)10(13)4-7;;/h2-4,8,16H,5-6H2,1H3,(H2,17,18,19);2*1H3
Standard InChI Key: JRKXIJDGTXBUII-UHFFFAOYSA-N
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 342.12 | Molecular Weight (Monoisotopic): 340.9987 | AlogP: 2.49 | #Rotatable Bonds: 5 |
Polar Surface Area: 98.07 | Molecular Species: ACID | HBA: 3 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 1.80 | CX Basic pKa: | CX LogP: 0.79 | CX LogD: -1.60 |
Aromatic Rings: 1 | Heavy Atoms: 20 | QED Weighted: 0.43 | Np Likeness Score: -0.32 |
References
1. Chofor R, Sooriyaarachchi S, Risseeuw MD, Bergfors T, Pouyez J, Johny C, Haymond A, Everaert A, Dowd CS, Maes L, Coenye T, Alex A, Couch RD, Jones TA, Wouters J, Mowbray SL, Van Calenbergh S.. (2015) Synthesis and bioactivity of β-substituted fosmidomycin analogues targeting 1-deoxy-D-xylulose-5-phosphate reductoisomerase., 58 (7): [PMID:25781377] [10.1021/jm5014264] |